Annual Report for Fiscal Year Ending December 31, 2024 (Form 20-F)
Operating and Financial Review and Prospects
You should read the following discussion and analysis of our financial condition and results of operations in conjunction with our consolidated financial statements and the related notes included elsewhere in this annual report. This discussion contains forward-looking statements that involve risks and uncertainties about our business and operations. Our actual results and the timing of selected events may differ materially from those anticipated in these forward-looking statements as a result of various factors, including those we describe under "Item 3. Key Information-D. Risk Factors" and elsewhere in this annual report.
|
A. |
Operating Results |
Key Factors Affecting Our Results of Operations
We benefit from the rapid development of healthcare and insurance industries, in particular health and life insurance industry, in
While our business is influenced by general factors affecting our industry, our results of operations are more directly affected by company-specific factors, including the following major ones:
Expansion and retention of consumer base
Brokerage income earned from insurance carriers through our insurance marketplace is the main source of our revenue, which is significantly affected by the number of insurance consumers on the
Our insurance consumers come from third-party traffic channels, traffic directed from our medical crowdfunding operation, and private domain contacts. In 2024, we moderately increased our investment in third-party traffic channels. In order to enhance overall user retention, we launched "Three Good Service" Initiative program to improve user satisfaction.
As of
First year premium per consumer
We believe that consumers choose our platform and repeat their purchases on our platform mainly because of the abundant product offerings, the convenience of online platform and the professional service of our team. As of
In China, consumer awareness of health protection and insurance products remains significantly lower than in developed countries, leading many users on our platform to initially purchase short-term products. As we serve a growing number of consumers, we gain valuable insights that allow us to work with insurers to co-create more appealing products. We are at the forefront of developing innovative solutions tailored for specific users, including those with pre-existing medical conditions who may struggle to qualify for traditional health insurance. As a result of increasing product and user diversity, the FYP per policy for short-term health insurance products rose from
Since introducing long-term health and life insurance products at the end of 2018, we have actively worked to raise consumer awareness and demonstrate the value of these products through our platform and service. The acquisition of Shenlanbao in 2023 further enhanced our service capabilities. Long-term health and life insurance products accounted for 31.3% and 30.4% of the FYP generated through our platforms in 2023 and 2024, respectively. The FYP per policy for long-term health and life insurance products increased from
Overall, the FYP per policy rose from
Cooperation with insurance carriers
We cooperate with insurance carriers to offer their standard insurance products or to design and develop tailor-made insurance products, and our relationship with insurance carriers is crucial to our success. As of
Operating efficiency and leverage
We have incurred significant costs and expenses in building our platform, growing our consumer base and developing capabilities in data analysis and technology. Our business model is highly scalable and our platform is built to support our continued growth.
We have always been mindful of the balance between business growth and costs and expenses. We have been endeavoring to improve selling and marketing efficiency. For example, we carefully select third-party user traffic channels, and further optimize and diversify our user acquisition channels. We have also been endeavoring to optimize our marketing strategies by adjusting our selling and marketing expenses and allocation of marketing resources. For instance, we moderately increased our investment in third-party traffic channels to promote certain new products in 2024.
Furthermore, we have invested in technology to accumulate and process multi-dimensional consumer data and transaction data, and have conducted in-depth analysis to improve our user acquisition and conversion, product design and risk management capabilities, which in tuimproves our overall operational margin. We have promoted technology advances in certain sales and customer service processes that effectively reduced costs, namely our own CRM system and AI applications.
Key Components of Results of Operations
Operating revenue, net
We generate net operating revenue primarily from (i) providing insurance brokerage services to insurance carriers, (ii) providing technical services to insurance carriers and other insurance brokerage or agency companies through our platforms, (iii) crowdfunding service fees from operating Waterdrop Medical Crowdfunding, and (iv) digital clinical trial solution income, mainly deriving from matching qualified and suitable patients for enrollment in clinical trials for biopharmaceutical companies and leading biotechnology companies. Starting from the second quarter of 2023, our chief operating decision makers have been managing the business, assessing the performance and allocating resources under the new operating segment structure. Operating segments are aggregated based on their similar economic characteristics, types of customers, types of services and products provided, the regulatory environments in which they operate and their management and reporting structure. We currently organize and report our business in the following segments: (i) insurance, which mainly includes
|
​ |
​ |
​ |
​ |
​ |
​ |
​ |
​ |
​ |
​ |
​ |
​ |
​ |
​ |
​ |
|
​ |
​ |
For the Year Ended |
||||||||||||
|
​ |
​ |
2022 |
​ |
2023 |
​ |
2024 |
||||||||
|
​ |
RMB |
(%) |
RMB |
(%) |
RMB |
US$ |
(%) |
|||||||
|
​ |
​ |
(in thousands, except for percentage data) |
||||||||||||
|
Segment revenue: |
||||||||||||||
|
Insurance(1) |
​ |
​ |
​ |
​ |
​ |
​ |
​ |
​ |
​ |
​ |
​ |
​ |
​ |
​ |
|
Brokerage income |
||||||||||||||
|
-Short-term insurance brokerage income |
1,628,902 |
58.1 |
1,381,855 |
52.5 |
1,309,432 |
179,392 |
47.2 |
|||||||
|
-Long-term insurance brokerage income |
714,426 |
25.5 |
823,305 |
31.3 |
1,013,406 |
138,836 |
36.6 |
|||||||
|
Brokerage income subtotal |
​ |
2,343,328 |
​ |
83.6 |
​ |
2,205,160 |
​ |
83.8 |
​ |
2,322,838 |
​ |
318,228 |
​ |
83.8 |
|
Technical service income |
215,832 |
7.7 |
​ |
135,755 |
5.2 |
​ |
40,939 |
5,608 |
​ |
1.5 |
||||
|
Insurance total |
​ |
2,559,160 |
​ |
91.3 |
​ |
2,340,915 |
​ |
89.0 |
​ |
2,363,777 |
​ |
323,836 |
​ |
85.3 |
|
Crowdfunding |
155,803 |
​ |
5.6 |
162,683 |
​ |
6.2 |
267,650 |
​ |
36,668 |
9.6 |
||||
|
Others |
​ |
86,805 |
​ |
3.1 |
​ |
127,109 |
​ |
4.8 |
​ |
140,394 |
​ |
19,234 |
​ |
5.1 |
|
Total |
2,801,768 |
100.0 |
2,630,707 |
100.0 |
2,771,821 |
379,738 |
100.0 |
|||||||
Note:
|
(1) |
We started to consolidate the financial results of Shenlanbao since |
Insurance. We derive insurance income primarily from commission fees generated from distributing insurance products underwritten by insurance carriers through our
Crowdfunding. Crowdfunding services primarily consist of providing technical and internet support, managing and reviewing the crowdfunding campaigns, and facilitating the collection and transfer of funds to the patients. The platform service fee is charged at a certain percentage of the withdrawal amount for a single crowdfunding campaign, subject to a capped maximum amount for a single crowdfunding campaign. The service fee is payable to us only upon the successful withdrawal of the funds by the patient.
Others. Other revenues mainly include income generated from digital clinical trial solution and other new initiatives. We derive digital clinical trial solution income primarily from matching qualified and suitable patients for enrollment in clinical trials for our customers that mainly include biopharmaceutical companies and leading biotechnology companies. We enter into patient recruitment contracts with these customers to match qualified patients with optimal suitability for enrollment in clinical trials. We typically charge a fixed unit price per successful match. Other new initiatives are those early-stage businesses. Revenues generated from the other new initiatives are not material, either individually or in aggregate.
For details of the segment information, see Note 12 "Segment Information" to our audited consolidated financial statements included elsewhere in this annual report.
Operating costs and expenses
Our operating costs and expenses consist of operating costs, sales and marketing expenses, general and administrative expenses, research and development expenses. The following table sets forth the breakdown of our total operating costs and expenses, in amounts and as percentages of net operating revenue for each of the years presented:
|
​ |
​ |
​ |
​ |
​ |
​ |
​ |
​ |
​ |
​ |
​ |
​ |
​ |
​ |
​ |
|
​ |
​ |
For the Year Ended |
||||||||||||
|
​ |
​ |
2022 |
​ |
2023 |
​ |
2024 |
||||||||
|
​ |
RMB |
(%) |
RMB |
(%) |
RMB |
US$ |
(%) |
|||||||
|
​ |
​ |
(in thousands, except for percentage data) |
||||||||||||
|
Operating costs and expenses: |
||||||||||||||
|
Operating costs |
1,019,362 |
36.4 |
1,195,544 |
45.5 |
1,314,740 |
180,119 |
47.4 |
|||||||
|
Sales and marketing expenses |
624,478 |
22.3 |
740,451 |
28.1 |
694,769 |
95,183 |
25.1 |
|||||||
|
General and administrative expenses |
388,651 |
13.9 |
402,395 |
15.3 |
367,652 |
50,368 |
13.3 |
|||||||
|
Research and development expenses |
291,290 |
10.3 |
299,060 |
11.4 |
216,502 |
29,661 |
7.8 |
|||||||
|
Total operating costs and expenses: |
2,323,781 |
82.9 |
2,637,450 |
100.3 |
2,593,663 |
355,331 |
93.6 |
|||||||
​
Operating costs. Operating costs primarily consists of (i) payroll and related expenses for insurance agents and customer service personnel, (ii) transaction fees charged by third-party payment platforms relating to insurance brokerage services, (iii) costs of referral and service fees, (iv) charges for the usage of the server and cloud service incurred for operational support of the platforms, and the expenses of facilities and equipment, such as depreciation expenses, rental and others, attributed to our principal operations, (v) costs for digital clinical trial solution consultants team, and (vi) costs for the crowdfunding consultants team and cost related to the information review and investigation of medical crowdfunding campaigns. We expect our operating costs to increase in absolute terms as our scale of business grows. However, as we improve the operating efficiency of our platform and achieve more economies of scale, we expect our operating costs as a percentage of our net operating revenue will decrease in the foreseeable future.
Sales and marketing expenses. Our sales and marketing expenses primarily consist of (i) marketing expenses for user acquisition and brand building, (ii) payroll and related expenses for employees involved in sales and marketing functions, (iii) outsourced sales and marketing service fees to third parties, and (iv) the associated expenses of facilities and equipment, such as depreciation expenses, rental and others.
General and administrative expenses. Our general and administrative expenses mainly consist of (i) payroll and related expenses for employees engaging in general corporate functions, including the share-based compensation expenses, (ii) professional service fees and other general corporate expenses, (iii) impairment loss of intangible assets and allowance for credit losses, and (iv) expenses associated with the use by these functions of facilities and equipment, such as rental and depreciation expenses.
Research and development expenses. Our research and development expenses mainly consist of (i) payroll and related expenses for employees involved in platform and new function development and significant improvement, and (ii) charges for the usage of the server and cloud service incurred to support research, design, and development activities by research and development personnel, as well as (iii) expenses of facilities and equipment, such as depreciation expenses, rental and others.
Taxation
The
According to the
Mainland China
Our subsidiaries, the consolidated VIEs and subsidiaries of the VIEs established in mainland China are mainly subject to statutory income tax at a rate of 25%. Certain enterprises benefit from a preferential tax rate of 15% under the PRC Enterprise Income Tax Law if they qualify as high and new technology enterprises, or engaged in encouraged industries and located in specific tax-advantaged areas. Besides, from
The PRC Enterprise Income Tax Law includes a provision specifying that legal entities organized outside of mainland China will be considered resident enterprises for the mainland China income tax purposes if the place of effective management or control is within mainland China. The implementation rules to the PRC Enterprise Income Tax Law provide that non-resident legal entities will be considered as mainland China resident enterprises if substantial and overall management and control over the manufacturing and business operations, personnel, accounting, properties, etc., occurs within mainland China. Despite the present uncertainties resulting from the limited tax guidance on the issue in mainland China, we do not believe that our entities organized outside of the mainland China should be treated as resident enterprises for the mainland China income tax purposes. If the tax authorities in mainland China subsequently determine that our company and our subsidiaries registered outside mainland China should be deemed resident enterprises, our company and our subsidiaries registered outside mainland China will be subject to the mainland China income tax, at a rate of 25%. See "Item 3. Key Information-D. Risk Factors-Risks Related to Doing Business in
The PRC Enterprise Income Tax Law also imposes a withholding income tax of 10% on dividends distributed by a foreign-invested enterprise to its immediate holding company outside of China, if such immediate holding company is considered as a non-resident enterprise without any establishment or place within China or if the received dividends have no connection with the establishment or place of such immediate holding company within China, unless such immediate holding company's jurisdiction of incorporation has a tax treaty with China that provides for a different withholding arrangement. The
Results of Operations
The following table sets forth a summary of our consolidated results of operations for the periods presented, both in absolute amount and as a percentage of our net operating revenue for the periods presented.
|
​ |
​ |
​ |
​ |
​ |
​ |
​ |
​ |
​ |
​ |
​ |
​ |
​ |
​ |
​ |
|
​ |
​ |
For the Year Ended |
||||||||||||
|
​ |
​ |
2022 |
​ |
2023 |
​ |
2024 |
||||||||
|
​ |
​ |
RMB |
​ |
(%) |
​ |
RMB |
​ |
(%) |
​ |
RMB |
​ |
US$ |
​ |
(%) |
|
​ |
​ |
(in thousands, except for percentage data) |
||||||||||||
|
Operating revenue, net |
2,801,768 |
100.0 |
2,630,707 |
100.0 |
2,771,821 |
379,738 |
100.0 |
|||||||
|
Operating costs and expenses |
​ |
​ |
​ |
​ |
​ |
​ |
​ |
​ |
||||||
|
Operating costs |
​ |
(1,019,362) |
(36.4) |
(1,195,544) |
(45.5) |
(1,314,740) |
(180,119) |
(47.4) |
||||||
|
Sales and marketing expenses(1) |
​ |
(624,478) |
(22.3) |
(740,451) |
(28.1) |
(694,769) |
(95,183) |
(25.1) |
||||||
|
General and administrative expenses |
​ |
(388,651) |
(13.9) |
(402,395) |
(15.3) |
(367,652) |
(50,368) |
(13.3) |
||||||
|
Research and development expenses |
​ |
(291,290) |
(10.3) |
(299,060) |
(11.4) |
(216,502) |
(29,661) |
(7.8) |
||||||
|
Total operating costs and expenses: |
​ |
(2,323,781) |
(82.9) |
(2,637,450) |
(100.3) |
(2,593,663) |
(355,331) |
(93.6) |
||||||
|
Operating profit/(loss) |
​ |
477,987 |
17.1 |
(6,743) |
(0.3) |
178,158 |
24,407 |
6.4 |
||||||
|
Other income |
​ |
​ |
​ |
​ |
​ |
​ |
​ |
​ |
||||||
|
Interest income |
​ |
81,713 |
2.9 |
136,043 |
5.2 |
149,121 |
20,429 |
5.4 |
||||||
|
Foreign currency exchange gain |
​ |
4,064 |
0.1 |
4,342 |
0.2 |
8,016 |
1,098 |
0.3 |
||||||
|
Others, net |
​ |
66,929 |
2.4 |
30,598 |
1.1 |
25,295 |
3,465 |
0.9 |
||||||
|
Profit before income tax |
​ |
630,693 |
22.5 |
164,240 |
6.2 |
360,590 |
49,399 |
13.0 |
||||||
|
Income tax expense |
​ |
(22,976) |
(0.8) |
(555) |
(0.0) |
(9,707) |
(1,330) |
(0.3) |
||||||
|
Net profit |
​ |
607,717 |
21.7 |
163,685 |
6.2 |
350,883 |
48,069 |
12.7 |
||||||
Note:
|
(1) |
The breakdown of sales and marketing expenses is as follows: |
|
​ |
​ |
​ |
​ |
​ |
​ |
​ |
​ |
​ |
|
​ |
​ |
For the Year Ended |
||||||
|
​ |
​ |
2022 |
​ |
2023 |
​ |
2024 |
||
|
​ |
​ |
RMB |
​ |
RMB |
​ |
RMB |
​ |
US$ |
|
​ |
​ |
(in thousands) |
||||||
|
Marketing expenses for user acquisition and brand building |
​ |
120,471 |
240,351 |
280,906 |
38,484 |
|||
|
Payroll and related expenses for employees |
​ |
316,795 |
390,534 |
297,451 |
40,751 |
|||
|
Expenses of facilities and equipment |
​ |
22,133 |
21,627 |
20,293 |
2,780 |
|||
|
Outsourced sales and marketing service fee to third parties |
​ |
149,249 |
63,512 |
75,994 |
10,411 |
|||
|
Others |
​ |
15,830 |
24,427 |
20,125 |
2,757 |
|||
|
Total sales and marketing expenses |
​ |
624,478 |
740,451 |
694,769 |
95,183 |
|||
​
Year Ended
Operating revenue, net
Our net operating revenue increased by 5.4% from
The net operating revenue from insurance-related businesses increased by 1.0% year-over-year, from
The net operating revenue from crowdfunding business increased by 64.5% from
The net operating revenue from other business increased by 10.5% from
Operating costs and expenses
Our total operating costs and expenses decreased by
Operating costs
Our operating costs increased by 10.0% from
Sales and marketing expenses
Our sales and marketing expenses decreased by 6.2% from
General and administrative expenses
Our general and administrative expenses decreased by 8.6% from
Research and development expenses
Our research and development expenses decreased by 27.6% from
Operating profit/(loss)
Our operating profit/(loss) increased from operating loss of
Interest income
Our interest income increased by 9.6% from
Net profit
As a result of the foregoing, our net profit for the year of 2024 was
Income tax expense
Income tax expense in 2024 was
Year Ended
Operating revenue, net
Our net operating revenue decreased by 6.1% from
The net operating revenue from insurance related business decreased by 8.5% from
The net operating revenue from crowdfunding business increased by 4.4% from
The net operating revenue from other business increased by 46.4% from
Operating costs and expenses
Our total operating costs and expenses increased by
Operating costs
Our operating costs increased by 17.3% from
Sales and marketing expenses
Our sales and marketing expenses increased by 18.6% from
General and administrative expenses
Our general and administrative expenses increased by 3.5% from
Research and development expenses
Our research and development expenses increased by 2.7% from
Operating profit/(loss)
Our operating profit/(loss) decreased by 101.4% from operating profit of
Interest income
Our interest income increased by 66.5% from
Net profit
As a result of the foregoing, our net profit for the year of 2023 was
Income tax expense
Income tax expense in 2023 was
Critical Accounting Estimates
We prepare our financial statements in accordance with
The selection of critical accounting policies, the judgments and other uncertainties affecting application of those policies and the sensitivity of reported results to changes in conditions and assumptions are factors that should be considered when reviewing our financial statements. We believe the following accounting policies involve the most significant judgments and estimates used in the preparation of our financial statements. You should read the following description of critical accounting estimates in conjunction with our consolidated financial statements and other disclosures included in this annual report.
Revenue Recognition
For insurance brokerage service, our performance obligation to the insurance carrier is satisfied and commission revenue is recognized at the point in time when an insurance policy becomes effective. We determine the transaction price of our contracts by estimating commissions that we expect to be entitled to over the premium collection term of the policy based on historical experience regarding premium retention and assumptions about future policyholder behavior and market conditions. Such estimates are 'constrained' in accordance with ASC 606. That is, we use the expected value method and only include estimated amounts in the transaction price to the extent it is probable that a significant reversal of cumulative revenue recognized for such transactions will not occur.
For certain long-term insurance products sold, we are also entitled to a performance bonus from insurance carriers if the retention rate for certain periods exceeds a predetermined percentage, or if its FYP exceeds a predetermined amount. We may also be asked to refund some commission to insurance companies if the retention rate for a certain period falls below a predetermined percentage. As the consideration for the bonus or the refund is contingent on the occurrence (or nonoccurrence) of a future event, the bonus or the refund represents variable consideration. Consistent with the policy described above, we use the expected value method to estimate the variable consideration and may constrain the estimate to the extent that it is probable that a significant reversal of revenue in the future will not occur.
Our significant estimates include estimating commissions to which we are entitled over the premium collection term, policyholder behavior and market conditions. They require subjective management judgment and any changes in those estimates may cause us to realize different amounts of revenues in the future periods.
Income Taxes
Current income taxes are provided for in accordance with the laws of the tax authorities. Deferred income taxes are recognized when temporary differences exist between the tax bases of assets and liabilities and their reported amounts in the financial statements. Net operating loss carry forwards and credits are applied using enacted statutory tax rates applicable to future years. Deferred tax assets are reduced by a valuation allowance when, in the opinion of management, it is more-likely-than-not that a portion of or all of the deferred tax assets will not be realized. Deferred tax assets are recognized to the extent that it is probable that taxable profits will be available against which deductible temporary differences can be utilized, which can require the use of accounting estimation and the exercise of judgement. The impact of an uncertain income tax position is recognized at the largest amount that is more-likely-than-not to be sustained upon audit by the tax authority. An uncertain income tax position will not be recognized if it has less than a 50% likelihood of being sustained. Interest and penalties on income taxes will be classified as a component of the provisions for income taxes.
Significant judgment is required in determining the valuation allowance. In assessing the need for a valuation allowance, we consider all sources of taxable income, including projected future taxable income, reversing taxable temporary differences and ongoing tax planning strategies. If it is determined that we are unable to realize a deferred tax asset, we would adjust the valuation allowance in the period in which such a determination is made, with a corresponding decrease to earnings.
Recent Accounting Pronouncements
A list of recently issued accounting pronouncements that are relevant to us is included in Note 2 "Recent accounting pronouncements" to our audited consolidated financial statements included elsewhere in this annual report.
|
B. |
Liquidity and Capital Resources |
We had net cash provided by operating activities of
In
We believe our cash on hand will be sufficient to meet our current and anticipated needs for working capital and capital expenditure requirement for at least the next 12 months.
Our restricted cash was
Our accounts receivable represents primarily brokerage commission fee receivable from insurance carriers and technical service fees receivable from insurance carriers. As of
Our contract assets are recorded for arrangements when we have provided the insurance brokerage services but for which the related commission payments are not yet due. Contract assets represent primarily the brokerage commission fee that is contingent upon the future premium payment of the insurance policy holders and retention-based bonus. As of
Our prepaid expense and other assets represent primarily (i) prepayments and deposits, (ii) the fund receivable from external payment service providers through which we collect and transfer insurance premiums to insurance carriers, and donors' donation received by our external payment service provider prior to those being transferred to custodian bank, and (iii) the advances to suppliers, such as the prepayments to third-party traffic channels. As of
Insurance premium payables represent insurance premiums we collected on behalf of insurance carriers from the insurance consumers but have not yet been remitted to insurance carriers as of the balance sheet dates. As of
Our accrued expenses and other current liabilities represent primarily (i) accrued marketing and customer service expenses, (ii) payroll and welfare payable, and (iii) payable related to medical crowdfunding business, which mainly represents the funds we collected through the third-party payment platforms that has not been transferred to custodian bank. Our accrued expenses and other current liabilities were
Although we consolidate the results of the VIEs, we only have access to the assets or earnings of the VIEs through our contractual arrangements with the VIEs and their shareholders. See "Item 4. Information on the
The majority of our operating revenue has been, and we expect that it is likely to continue to be, in the form of Renminbi. Under existing foreign exchange regulations in mainland China, payments of current account items, including profit distributions, interest payments and trade and service-related foreign exchange transactions, can be made in foreign currencies without prior SAFE approval as long as certain routine procedural requirements are fulfilled. Therefore, our subsidiaries mainland China are allowed to pay dividends in foreign currencies to us without prior SAFE approval by following certain routine procedural requirements. However, current regulations permit in mainland China our subsidiaries in mainland China to pay dividends to us only out of its accumulated profits, if any, determined in accordance with accounting standards and regulations in mainland China. Our subsidiaries in mainland China are required to set aside at least 10% of its after-tax profits after making up previous years' accumulated losses each year, if any, to fund certain reserve funds until the total amount set aside reaches 50% of its registered capital. These reserves are not distributable as cash dividends. Historically, our subsidiaries in mainland China have not paid dividends to us, and they will not be able to pay dividends until they generate accumulated profits. Furthermore, capital account transactions, which include foreign direct investment and loans, must be approved by and/or registered with SAFE, its local branches and certain local banks.
As a
The following table sets forth the movements of our cash flows for the periods presented:
|
​ |
​ |
​ |
​ |
​ |
​ |
​ |
​ |
​ |
|
​ |
​ |
For the Year Ended |
||||||
|
​ |
​ |
2022 |
​ |
2023 |
​ |
2024 |
||
|
​ |
​ |
RMB |
​ |
RMB |
​ |
RMB |
​ |
US$ |
|
​ |
​ |
(in thousands) |
||||||
|
Selected Consolidated Cash Flow Data: |
||||||||
|
Net cash provided by operating activities |
​ |
765,705 |
406,516 |
437,250 |
59,904 |
|||
|
Net cash (used in)/provided by investing activities |
​ |
(139,819) |
(1,172,960) |
291,637 |
39,953 |
|||
|
Net cash used in financing activities |
​ |
(57,457) |
(377,238) |
(198,579) |
(27,205) |
|||
|
Effect of exchange rate changes on cash and cash equivalents |
​ |
37,723 |
26,173 |
2,577 |
353 |
|||
|
Net increase/(decrease) in cash and cash equivalents and restricted cash |
​ |
606,152 |
(1,117,509) |
532,885 |
73,005 |
|||
|
Total cash and cash equivalents and restricted cash at beginning of year |
​ |
1,485,383 |
2,091,535 |
974,026 |
133,441 |
|||
|
Total cash and cash equivalents and restricted cash at end of year |
​ |
2,091,535 |
974,026 |
1,506,911 |
206,446 |
|||
​
Operating activities
Net cash provided by operating activities in 2024 was
Specifically, the decrease in insurance premium payables was primarily due to the decrease of turnover days. The increase in contract assets and the increase in accounts receivable were primarily due to the increase in the FYP generated through our platform. The increase in accrued expenses and other current liabilities was primarily due to (i) the increase in accrued marketing and customer service expenses, and (ii) the increase in payroll and welfare payable.
Net cash provided by operating activities in 2023 was
Specifically, the decrease in prepaid expense and other assets was primarily due to the decrease in the advances to suppliers as a result of decrease in the prepayments to third-party traffic channels. The increase in insurance premium payables was primarily due to the increase in the FYP generated through our platform from
Net cash provided by operating activities in 2022 was
Specifically, the decreases in insurance premium payables and contract assets were primarily due to the downsize in the FYP generated through our platform in 2022, which was due to the decrease in the number of new consumers resulting from our reduced reliance on third-party user acquisition channels in 2022. The increase in accounts receivable was primarily due to the increase of turnover days. The decrease in prepaid expense and other assets was primarily due to the decrease in fund receivable from external payment service providers through which we collect various fund in our operation. The increase in accrued expenses and other current liabilities was primarily due to the increase in the accrued customer service expense payable to third-party companies.
Investing activities
Net cash provided by investing activities in 2024 was
Net cash used in investing activities in 2023 was
Net cash used in investing activities in 2022 was
Financing activities
Net cash used in financing activities in 2024 was
Net cash used in financing activities in 2023 was
Net cash used in financing activities in 2022 was
Material cash requirements
Our material cash requirements as of
Our capital expenditures primarily represent cash paid for purchase of property, equipment and software. We made capital expenditures of
Our operating lease commitments consist of the commitments under the lease agreements for our office premises. Contractual obligation as of
We intend to fund our existing and future material cash requirements with our existing cash balance and other financing alternatives. We will continue to make cash commitments, including capital expenditures, to support the growth of our business.
We have not entered into any financial guarantees or other commitments to guarantee the payment obligations of any third parties. We do not have retained or contingent interests in assets transferred. We have not entered into contractual arrangements that support the credit, liquidity or market risk for transferred assets. We do not have obligations that arise or could arise from variable interests held in an unconsolidated entity, or obligations related to derivative instruments that are both indexed to and classified in our own equity, or not reflected in the statement of financial position.
Other than as discussed above, we did not have any significant capital and other commitments, long-term obligations or guarantees as of
Holding Company Structure
If our WFOE or any newly formed subsidiaries in mainland China incur debt on their own behalf in the future, the instruments governing their debt may restrict their ability to pay dividends to us. In addition, our WFOE is permitted to pay dividends to us only out of its retained earnings, if any, as determined in accordance with the accounting standards and regulations in mainland China. Under the law in mainland China, each of our WFOE and the VIEs is required to set aside at least 10% of its after-tax profits each year, if any, to fund certain statutory reserve funds until such reserve funds reach 50% of its registered capital. In addition, our WFOE may allocate a portion of its after-tax profits based on the accounting standards in mainland China to enterprise expansion funds and staff bonus and welfare funds at its discretion, and the VIEs may allocate a portion of their after-tax profits based on the accounting standards in mainland China to a discretionary surplus fund at its discretion. The statutory reserve funds and the discretionary funds are not distributable as cash dividends. Remittance of dividends by a wholly foreign-owned company out of China is subject to examination by the banks designated by SAFE. As of
|
C. |
Research and Development |
See "Item 4. Information on the
|
D. |
Trend Information |
Other than as disclosed elsewhere in this annual report, we are not aware of any trends, uncertainties, demands, commitments or events for the period since
|
E. |
Critical Accounting Estimates |
For our critical accounting estimates, see "Item 5. Operating and Financial Review and Prospects-Critical Accounting Estimates."
|
F. |
Safe Harbor |
See "Forward-Looking Information" on page 2 of this annual report.
Item 6.Directors, Senior Management and Employees
|
A. |
Directors and Senior Management |
The following table sets forth information regarding our executive officers and directors.
|
​ |
​ |
​ |
​ |
​ |
|
Directors and Executive Officers |
Age |
Position/Title |
||
|
|
Chairman of the Board of Directors and Chief Executive Officer |
|||
|
|
Director, Vice President of Finance and General Manager of International Business |
|||
|
|
Director and General Manager of Insurance Technology Business |
|||
|
|
Director |
|||
|
|
Director |
|||
|
|
Director |
|||
|
|
Independent Director |
|||
|
|
Independent Director |
|||
|
|
Independent Director |
|||
|
|
Head of Finance |
|||
|
|
​ |
​ |
Vice President of Human Resources and Organization Development |
|
|
|
Head of Research and Development |
|||
|
|
Head of Legal |
​
Mr.
Mr.
Mr.
Mr.
Mr.
Ms.
Mr.
Mr.
Mr.
Ms.
Ms.
Mr.
Ms.
|
B. |
Compensation |
Compensation of Directors and Executive Officers
In 2024, we paid an aggregate of
Employment Agreements and Indemnification Agreements
We have entered into employment agreements with each of our executive officers. Under these agreements, each of our executive officers is employed for a specified time period. We may terminate employment for cause, at any time, for certain acts of the executive officer, such as continued failure to satisfactorily perform, willful misconduct or gross negligence in the performance of agreed duties, conviction or entry of a guilty or nolo contendere plea of any felony or any misdemeanor involving moral turpitude, or dishonest act that results in material to our detriment or material of the employment agreement. We may also terminate an executive officer's employment without cause upon 60-day advance written notice. In such case of termination by us, we will provide severance payments to the executive officer as may be agreed between the executive officer and us. The executive officer may resign at any time with a 60-day advance written notice.
Each executive officer has agreed to hold, both during and after the termination or expiry of his or her employment agreement, in strict confidence and not to use, except as required in the performance of his or her duties in connection with the employment or pursuant to applicable law, any of our confidential information or trade secrets, any confidential information or trade secrets of our clients or prospective clients, or the confidential or proprietary information of any third party received by us and for which we have confidential obligations. The executive officers have also agreed to disclose in confidence to us all inventions, designs and trade secrets which they conceive, develop or reduce to practice during the executive officer's employment with us and to assign all right, title and interest in them to us, and assist us in obtaining and enforcing patents, copyrights and other legal rights for these inventions, designs and trade secrets.
In addition, each executive officer has agreed to be bound by non-competition and non-solicitation restrictions during the term of his or her employment and typically for one year following the last date of employment. Specifically, each executive officer has agreed not to (i) solicit from any customer doing business with us during the effective term of the employment agreement business of the same or of a similar nature to our business; (ii) solicit from any of our known potential customer business of the same or of a similar nature to that which has been the subject of our known written or oral bid, offer or proposal, or of substantial preparation with a view to making such a bid, proposal or offer; (iii) solicit the employment or services of, or hire or engage, any person who is known to be employed or engaged by us; or (iv) otherwise interfere with our business or accounts, including, but not limited to, with respect to any relationship or agreement between any vendor or supplier and us.
We have also entered into indemnification agreements with each of our directors and executive officers. Under these agreements, we agree to indemnify our directors and executive officers against certain liabilities and expenses incurred by such persons in connection with claims made by reason of their being a director or officer of our company.
Share Incentive Plans
2018 Share Incentive Plan
In
The following paragraphs summarize the principal terms of the 2018 Plan.
Type of Awards. The 2018 Plan permits the awards of options, restricted shares, restricted share units or any other types of awards approved by the plan administrator or the board of directors.
Award Agreement. Awards granted under the 2018 Plan are evidenced by an award agreement that sets forth the terms, conditions and limitations for each award, the provisions applicable in the event that the grantee's employment or service terminates, and our authority to unilaterally or bilaterally amend, modify, suspend, cancel or rescind the award.
Eligibility. We may grant awards to our directors, employees and consultants of our company. However, we may grant options that are intended to qualify as incentive share options only to our employees and employees of our parent companies or subsidiaries.
Vesting Schedule. In general, the plan administrator determines the vesting schedule, which is specified in the award agreement. Exercise Price. The plan administrator determines the exercise price for each award, which is stated in the award agreement.
Term of the Awards. Options that are vested and exercisable will terminate if they are not exercised prior to the time as the plan administrator determines at the time of grant. However, the maximum exercisable term is ten years from the date of a grant.
Transfer Restrictions. Awards may not be transferred in any manner by the participant other than in accordance with the exceptions provided in the 2018 Plan or the award agreement or otherwise determined by the plan administrator, such as transfers by will or the laws of descent and distribution.
Termination and Amendment. Unless terminated earlier, the 2018 Plan has a term of ten years from its date of effectiveness. Our board of directors and the plan administrator have the authority to terminate, amend or modify the plan. However, no such action may adversely affect in any material way any awards previously granted without the written consent of the participant.
2021 Share Incentive Plan
In
The following paragraphs summarize the principal terms of the 2021 Plan.
Types of Awards. The 2021 Plan permits the awards of options, restricted shares, restricted share units or any other type of awards approved by the plan administrator or the board of directors.
Award Agreement. Awards granted under the 2021 Plan are evidenced by an award agreement that sets forth the terms, conditions and limitations for each award, the provisions applicable in the event that the grantee's employment or service terminates, and our authority to unilaterally or bilaterally amend, modify, suspend, cancel or rescind the award.
Eligibility. We may grant awards to our employees, directors and consultants of our company. However, we may grant options that are intended to qualify as incentive share options only to our employees and employees of our subsidiaries.
Vesting Schedule. In general, the plan administrator determines the vesting schedule, which is specified in the award agreement. Exercise Price. The plan administrator determines the exercise price for each award, which is stated in the award agreement.
Term of the Awards. Options that are vested and exercisable will terminate if they are not exercised prior to the time as the plan administrator determines at the time of grant. However, the maximum exercisable term is ten years from the date of a grant.
Transfer Restrictions. Awards may not be transferred in any manner by the participant other than in accordance with the exceptions provided in the 2021 Plan or the award agreement or otherwise determined by the plan administrator, such as transfers by will or the laws of descent and distribution.
Termination and Amendment. Unless terminated earlier, the 2021 Plan has a term of ten years from its date of effectiveness. Our board of directors has the authority to amend or terminate the plan. However, no such action may adversely affect in any material way any awards previously granted without the written consent of the participant.
The following table summarizes, as of
|
​ |
​ |
​ |
​ |
​ |
​ |
​ |
​ |
​ |
|
​ |
Ordinary |
​ |
​ |
​ |
||||
|
​ |
​ |
Shares |
​ |
​ |
​ |
​ |
​ |
​ |
|
​ |
​ |
Underlying |
​ |
​ |
​ |
​ |
​ |
​ |
|
​ |
​ |
Options and |
​ |
​ |
​ |
​ |
​ |
​ |
|
​ |
​ |
Restricted |
​ |
Exercise Price |
​ |
​ |
​ |
​ |
|
|
​ |
Share Units |
​ |
(US$/Share) |
​ |
Date of Grant |
​ |
Date of Expiration |
|
|
​ |
* |
0.003 |
|
|
|||
|
​ |
​ |
* |
0.08 |
|
|
|||
|
​ |
​ |
*(1) |
N/A |
|
- |
|||
|
​ |
​ |
*(1) |
N/A |
|
- |
|||
|
​ |
​ |
*(1) |
N/A |
|
- |
|||
|
​ |
​ |
*(1) |
N/A |
|
- |
|||
|
​ |
​ |
*(1) |
N/A |
|
- |
|||
|
|
​ |
* |
0.08 |
|
|
|||
|
​ |
​ |
*(1) |
N/A |
|
- |
|||
|
|
​ |
* |
0.08 |
|
|
|||
|
​ |
​ |
*(1) |
N/A |
|
- |
|||
|
|
​ |
*(1) |
N/A |
|
- |
|||
|
|
​ |
*(1) |
N/A |
|
- |
|||
|
​ |
​ |
*(1) |
N/A |
|
- |
|||
|
​ |
​ |
*(1) |
N/A |
|
- |
|||
|
|
​ |
* |
0.003 |
|
|
|||
|
​ |
​ |
* |
0.003 |
|
|
|||
|
​ |
​ |
* |
​ |
0.08 |
​ |
|
​ |
|
|
​ |
​ |
*(1) |
​ |
N/A |
​ |
|
​ |
- |
|
​ |
​ |
*(1) |
​ |
N/A |
​ |
|
​ |
- |
|
​ |
​ |
*(1) |
​ |
N/A |
​ |
|
​ |
- |
|
​ |
​ |
*(1) |
​ |
N/A |
​ |
|
​ |
- |
|
​ |
​ |
*(1) |
​ |
N/A |
​ |
|
​ |
- |
|
|
​ |
* |
​ |
0.08 |
​ |
|
​ |
|
|
​ |
​ |
*(1) |
​ |
N/A |
​ |
|
​ |
- |
|
​ |
​ |
*(1) |
​ |
N/A |
​ |
|
​ |
- |
|
​ |
​ |
*(1) |
​ |
N/A |
​ |
|
​ |
- |
|
|
​ |
* |
​ |
0.08 |
​ |
|
​ |
|
|
​ |
​ |
*(1) |
​ |
N/A |
​ |
|
​ |
- |
|
​ |
​ |
*(1) |
​ |
N/A |
​ |
|
​ |
- |
|
​ |
​ |
*(1) |
​ |
N/A |
​ |
|
​ |
- |
|
​ |
​ |
*(1) |
​ |
N/A |
​ |
|
​ |
- |
|
All directors and executive officers as a group |
​ |
37,149,130 |
​ |
​ |
​ |
​ |
​ |
​ |
Note
|
* |
Less than 1% of our total ordinary shares on an as-converted basis outstanding as of |
|
(1) |
Represents restricted share units. |
As of
|
C. |
Board Practices |
Board of Directors
Our board of directors consists of nine directors. A director is not required to hold any shares in our company by way of qualification. A director who is in any way, whether directly or indirectly, interested in a contract or transaction or proposed contract or transaction with our company is required to declare the nature of his interest at a meeting of our directors. Subject to the
Committees of the Board of Directors
We have established three committees under the board of directors: an audit committee, a compensation committee and a nominating and corporate governance committee. We have adopted a charter for each of the three committees. Each committee's members and functions are described below.
Audit Committee. Our audit committee consists of
|
· |
appointing the independent auditors and pre-approving all auditing and non-auditing services permitted to be performed by the independent auditors; |
|
· |
reviewing with the independent auditors any audit problems or difficulties and management's response; |
|
· |
discussing the annual audited financial statements with management and the independent auditors; |
|
· |
reviewing the adequacy and effectiveness of our accounting and internal control policies and procedures and any steps taken to monitor and control major financial risk exposures; |
|
· |
reviewing and approving all proposed related party transactions; |
|
· |
meeting separately and periodically with management and the independent auditors; and |
|
· |
monitoring compliance with our code of business conduct and ethics, including reviewing the adequacy and effectiveness of our procedures to ensure proper compliance. |
Compensation Committee. Our compensation committee consists of
|
· |
reviewing and approving, or recommending to the board for its approval, the compensation for our chief executive officer and other executive officers; |
|
· |
reviewing and recommending to the board for determination with respect to the compensation of our non-employee directors; |
|
· |
reviewing periodically and approving any incentive compensation or equity plans, programs or similar arrangements; and |
|
· |
selecting compensation consultant, legal counsel or other adviser only after taking into consideration all factors relevant to that person's independence from management. |
Nominating and Corporate Governance Committee. Our nominating and corporate governance committee consists of
|
· |
selecting and recommending to the board nominees for election by the shareholders or appointment by the board; |
|
· |
reviewing annually with the board the current composition of the board with regards to characteristics such as independence, knowledge, skills, experience and diversity; |
|
· |
making recommendations on the frequency and structure of board meetings and monitoring the functioning of the committees of the board; and |
|
· |
advising the board periodically with regards to significant developments in the law and practice of corporate governance as well as our compliance with applicable laws and regulations, and making recommendations to the board on all matters of corporate governance and on any remedial action to be taken. |
Duties of Directors
Under
Our board of directors has all the powers necessary for managing, and for directing and supervising, our business affairs. The functions and powers of our board of directors include, among others:
|
· |
convening shareholders' annual and extraordinary general meetings and reporting its work to shareholders at such meetings; |
|
· |
declaring dividends and distributions; |
|
· |
appointing officers and determining the term of office of the officers; |
|
· |
exercising the borrowing powers of our company and mortgaging the property of our company; and |
|
· |
approving the transfer of shares in our company, including the registration of such shares in our share register. |
Terms of Directors and Officers
Our directors may be elected by an ordinary resolution of our shareholders. Alternatively, our board of directors may, by the affirmative vote of a simple majority of the directors present and voting at a board meeting appoint any person as a director to fill a casual vacancy on our board or as an addition to the existing board. Our directors are not automatically subject to a term of office and hold office until such time as they are removed from office by an ordinary resolution of our shareholders. In addition, a director will cease to be a director if he (i) becomes bankrupt or makes any arrangement or composition with his creditors; (ii) dies or is found to be or becomes of unsound mind; (iii) resigns his office by notice in writing; (iv) without special leave of absence from our board, is absent from meetings of our board for three consecutive meetings and our board resolves that his office be vacated; or (v) is removed from office pursuant to any other provision of our articles of association.
Our officers are appointed by and serve at the discretion of the board of directors, and may be removed by our board of directors.
|
D. |
Employees |
We had 2,719, 2,960 and 3,057 full-time employees as of
|
​ |
​ |
​ |
|
​ |
​ |
Number of |
|
Function |
Employees |
|
|
Operating |
1,803 |
|
|
Sales and marketing |
626 |
|
|
General and administrative |
299 |
|
|
Research and development |
329 |
|
|
Total |
3,057 |
​
Our success depends on our ability to attract, motivate, train and retain qualified personnel. We believe we offer our employees competitive compensation packages and an environment that encourages self-development and, as a result, have generally been able to attract and retain qualified employees. We have established comprehensive training programs covering new employee training, customized training as well as leadership training. Depending on the position, employee reviews are conducted either quarterly or annually.
As required by laws and regulations in mainland China, we participate in various employee social security plans that are organized by municipal and provincial governments including, among other things, pension, medical insurance, unemployment insurance, maternity insurance, work-related injury insurance and housing fund plans through a benefit contribution plan mandated by the PRC government. We are required under the law in mainland China to make contributions to employee benefit plans at specified percentages of the salaries, bonuses and certain allowances of our employees, up to a maximum amount specified by the local government from time to time.
We enter into standard employment agreements, as well as confidentiality and non-compete agreements with our employees in accordance with market practice.
We believe that we maintain a good working relationship with our employees, and we have not experienced any material labor disputes. None of our employees are represented by a collective bargaining agreements. Working together, our employees build our corporate culture that cares for individuals, fosters innovation, pursues credibility and integrity, and embraces changes, and has significantly contributed to our achievements.
|
E. |
Share Ownership |
Except as specifically noted, the following table sets forth information with respect to the beneficial ownership of our ordinary shares on an as-converted basis as of
|
· |
each of our directors and executive officers; and |
|
· |
each of our principal shareholders who beneficially own more than 5% of our total issued and outstanding shares. |
The calculations in the table below are based on 2,814,720,121 Class A ordinary shares (excluding 467,536,400 Class A ordinary shares, comprising of Class A ordinary shares issued to the depositary for bulk issuance of ADSs and reserved for future issuances upon the exercise or vesting of awards granted under share incentive plans, and Class A ordinary shares in the form of ADSs held in treasury) and 801,904,979 Class B ordinary shares, issued and outstanding as of
Beneficial ownership is determined in accordance with the rules and regulations of the
|
​ |
​ |
​ |
​ |
​ |
​ |
​ |
​ |
​ |
​ |
​ |
|
​ |
​ |
Ordinary Shares Beneficially Owned |
||||||||
|
​ |
​ |
​ |
​ |
​ |
​ |
Total Ordinary |
​ |
% of Total |
​ |
​ |
|
​ |
​ |
Class A |
​ |
Class B |
​ |
Shares on |
​ |
Ordinary |
​ |
​ |
|
​ |
​ |
Ordinary |
​ |
Ordinary |
​ |
an As-converted |
​ |
Shares on an As- |
​ |
% of Aggregate |
|
​ |
Shares |
Shares |
Basis |
converted Basis |
Voting Power |
|||||
|
Directors and Executive Officers**: |
||||||||||
|
|
​ |
4,000 |
801,904,979 |
801,908,979 |
22.2 |
71.9 |
||||
|
|
​ |
86,386,000 |
- |
86,386,000 |
2.4 |
0.9 |
||||
|
|
​ |
* |
- |
* |
* |
* |
||||
|
|
​ |
- |
- |
- |
- |
- |
||||
|
|
​ |
- |
- |
- |
- |
- |
||||
|
|
​ |
- |
- |
- |
- |
- |
||||
|
|
​ |
* |
- |
* |
* |
- |
||||
|
|
​ |
* |
- |
* |
* |
- |
||||
|
|
​ |
* |
- |
* |
* |
- |
||||
|
|
​ |
* |
​ |
- |
​ |
* |
​ |
* |
​ |
* |
|
|
​ |
* |
- |
* |
* |
* |
||||
|
|
​ |
* |
- |
* |
* |
* |
||||
|
|
​ |
* |
- |
* |
* |
* |
||||
|
All Directors and Executive Officers as a Group |
112,817,450 |
801,904,979 |
914,722,429 |
25.3 |
73.1 |
|||||
|
Principal Shareholders: |
​ |
​ |
​ |
​ |
​ |
|||||
|
|
​ |
- |
801,904,979 |
801,904,979 |
22.2 |
71.9 |
||||
|
Entities affiliated with |
​ |
830,085,007 |
- |
830,085,007 |
23.0 |
8.3 |
||||
|
Investment funds affiliated with |
​ |
470,735,258 |
- |
470,735,258 |
13.0 |
4.7 |
||||
|
|
206,362,384 |
- |
206,362,384 |
5.7 |
2.1 |
|||||
Notes:
|
* |
Less than 1% of our total ordinary shares on an as-converted basis outstanding as of |
|
** |
Except as indicated otherwise below, the business address of our directors and executive officers is Block C, Wangjing Science and Technology Park, No. |
|
†|
For each person or group included in this column, percentage of total voting power represents voting power based on both Class A and Class B ordinary shares held by such person or group with respect to all outstanding shares of our Class A and Class B ordinary shares as a single class. Each holder of our Class A ordinary shares is entitled to one vote per share. Each holder of our Class B ordinary shares is entitled to nine votes per share. Our Class B ordinary shares are convertible at any time by the holder into Class A ordinary shares on a one-for-one basis, while Class A ordinary shares are not convertible into Class B ordinary shares under any circumstances. In addition, the Class B ordinary shares held by Mr. |
|
(1) |
Represents (i) 801,904,979 Class B ordinary share held of record by |
The registered address of
|
(2) |
Represents 86,386,000 Class A Ordinary Shares held of record by |
The registered address of
|
(3) |
Represents (i) 805,085,007 Class A ordinary shares directly held by |
|
(4) |
To our best knowledge, represents (i) 434,235,258 Class A ordinary shares directly held by |
|
(5) |
Represents 206,362,384 Class A ordinary shares directly held by |
To our knowledge and with reference to the addresses in our shareholder register, as of
We are not aware of any arrangement that may, at a subsequent date, result in a change of control of our company.
F. Disclosure of Registrant's Action to Recover Erroneously Awarded Compensation
Not applicable.
Item 7.Major Shareholders and Related Party Transactions
|
A. |
Major Shareholders |
Please refer to "Item 6. Directors, Senior Management and Employees-E. Share Ownership."
|
B. |
Related Party Transactions |
Contractual Arrangements with the Variable Interest Entities and Their Respective Shareholders
See "Item 4. Information on the
Employment Agreements and Indemnification Agreements
See "Item 6. Directors, Senior Management and Employees-B. Compensation."
Share Incentive Plans
See "Item 6. Directors, Senior Management and Employees-B. Compensation."
Other Related Party Transactions
Transactions with
We provide advertising services to
Shareholders Agreement
We entered into our fifth amended and restated shareholders agreement on
Registration Rights
We have granted certain registration rights to our shareholders. Set forth below is a description of the registration rights granted under the shareholders agreement.
Demand Registration Rights. Holders of at least 25% of the voting power of the then outstanding registrable securities held by all such holders may request in writing that we effect a registration of at least 20%, or any less percentage if the anticipated gross proceeds would exceed
Piggyback Registration Rights. If we propose to file a registration statement for a public offering of our securities, we shall offer shareholders an opportunity to include in the registration all or any part of the registrable securities held by such holders. If the managing underwriters of any underwritten offering determine that marketing factors require a limitation of the number of shares to be underwritten, and the number of shares that may be included in the registration and the underwriting shall be allocated (i) first, to us, (ii) second, to each holder requesting inclusion of its registrable securities in such registration statement on a pro rata basis based on the total number of registrable securities then held by each such holder; provided that at least 25% of the registrable securities requested by the holders to be included in the underwriting and registration shall be so included and all shares that are not registrable securities shall first be excluded from such registration and underwriting before any registrable securities are so excluded.
Form F-3 Registration Rights. Our shareholders may request us in writing to file an unlimited number of registration statements on Form F-3 if we qualify for registration on Form F-3. We have a right to defer filing of a registration statement for the period during which such filing would be materially detrimental to us or our members on the condition that we furnish to the holders requesting registration a certificate signed by our chief executive officer stating that in the good faith judgment of our board of directors, it would be materially detrimental to us and our shareholders for such registration statement to be filed in the near future. However, we cannot exercise the deferral right more than once during any 12-month period for a period of not more than 60 days and cannot register any other securities during such 60-day period. We are obligated to effect no more than two demand registrations that have been declared effective within any 12-month period.
Expenses of Registration. We will bear all registration expenses, other than underwriting discounts and selling commissions applicable to sale of registrable securities. However, expenses in excess of
|
C. |
Interests of Experts and Counsel |
Not applicable.
Item 8.Financial Information
|
A. |
Consolidated Statements and Other Financial Information |
We have appended consolidated financial statements filed as part of this annual report.
Legal Proceedings
We may from time to time be subject to various legal or administrative claims and proceedings arising in the ordinary course of business. Litigation or any other legal or administrative proceeding, regardless of the outcome, is likely to result in substantial cost and diversion of our resources, including our management's time and attention.
On
Dividend Policy
Our board of directors has discretion on whether to distribute dividends, subject to certain requirements of
In
We are a holding company incorporated in the
If we pay any dividends on our Class A ordinary shares, we will pay those dividends which are payable in respect of the Class A ordinary shares underlying the ADSs to the depositary, as the registered holder of such Class A ordinary shares, and the depositary then will pay such amounts to the ADS holders in proportion to the Class A ordinary shares underlying the ADSs held by such ADS holders, subject to the terms of the deposit agreement, including the fees and expenses payable thereunder. Cash dividends on our Class A ordinary shares, if any, will be paid in
|
B. |
Significant Changes |
Except as disclosed elsewhere in this annual report, we have not experienced any significant changes since the date of our audited consolidated financial statements included in this annual report.
|
A. |
Offering and Listing Details |
Our ADSs have been listed on the
|
B. |
Plan of Distribution |
Not applicable.
|
C. |
Markets |
Our ADSs have been listed on the
|
D. |
Selling Shareholders |
Not applicable.
|
E. |
Dilution |
Not applicable.
|
F. |
Expenses of the Issue |
Not applicable.
​
Item 10.Additional Information
​
|
A. |
ShareCapital |
Not applicable.
|
B. |
Memorandum and Articles of Association |
The following are summaries of material provisions of our currently effective memorandum and articles of association and of the Companies Act, insofar as they relate to the material terms of our ordinary shares.
Objects of Our Company. Under our current memorandum and articles of association, the objects of our company are unrestricted and we have the full power and authority to carry out any object not prohibited by the laws of the
Ordinary Shares. Our ordinary shares are divided into Class A ordinary shares and Class B ordinary shares. Holders of our Class A ordinary shares and Class B ordinary shares have the same rights except for voting and conversion rights. Each Class A ordinary share shall entitle the holder thereof to one vote on all matters subject to vote at our general meetings, and each Class B ordinary share shall entitle the holder thereof to nine votes on all matters subject to vote at our general meetings. Our ordinary shares are issued in registered form and are issued when registered in our register of members. We may not issue shares to bearer. Our shareholders who are nonresidents of the
Conversion. Class B ordinary shares may be converted into the same number of Class A ordinary shares at the option of the holders thereof at any time, while Class A ordinary shares cannot be converted into Class B ordinary shares under any circumstances. Upon any sale, transfer, assignment or disposition of Class B ordinary shares by a holder thereof to any person other than our founder, chairman and chief executive officer, Mr.
Dividends. The holders of our ordinary shares are entitled to such dividends as may be declared by our board of directors or declared by our shareholders by ordinary resolution (provided that no dividend may be declared by our shareholders which exceeds the amount recommended by our directors). Our current memorandum and articles of association provide that dividends may be declared and paid out of our profits, realized or unrealized, or from any reserve set aside from profits which our board of directors determine is no longer needed. Under the laws of the
Voting Rights. Holders of Class A ordinary shares and Class B ordinary shares shall, at all times, vote together as one class on all matters submitted to a vote by the members at any general meeting of the Company. Each Class A ordinary share shall be entitled to one vote on all matters subject to the vote at general meetings of our Company, and each Class B ordinary share shall be entitled to nine votes on all matters subject to the vote at general meetings of our Company. Voting at any meeting of shareholders is by show of hands unless a poll (before or on the declaration of the result of the show of hands) is demanded. A poll may be demanded by the chairperson of such meeting or any one shareholder present in person or by proxy.
An ordinary resolution to be passed at a meeting by the shareholders requires the affirmative vote of a simple majority of the votes attaching to the ordinary shares cast at a meeting, while a special resolution requires the affirmative vote of no less than two-thirds of the votes cast attaching to the outstanding and issued ordinary shares cast at a meeting. A special resolution will be required for important matters such as a change of name or making changes to our current memorandum and articles of association. Our shareholders may, among other things, divide or combine their shares by ordinary resolution.
General Meetings of Shareholders. As a
Shareholders' general meetings may be convened by a majority of our board of directors. Advance notice of at least seven days is required for the convening of our annual general shareholders' meeting (if any) and any other general meeting of our shareholders. A quorum required for any general meeting of shareholders consists of at least one shareholder present or by proxy, representing not less than one-third of all votes attaching to the issued and outstanding shares in our company entitled to vote at the general meeting.
The Companies Act provides shareholders with only limited rights to requisition a general meeting, and does not provide shareholders with any right to put any proposal before a general meeting. However, these rights may be provided in a company's articles of association. Our current memorandum and articles of association provide that upon the requisition of any one or more of our shareholders who together hold shares which carry in aggregate not less than one-third of all votes attaching to the issued and outstanding shares of our company entitled to vote at general meetings, our board will convene an extraordinary general meeting and put the resolutions so requisitioned to a vote at such meeting. However, our current memorandum and articles of association do not provide our shareholders with any right to put any proposals before annual general meetings or extraordinary general meetings not called by such shareholders.
Transfer of Ordinary Shares. Subject to the restrictions set out in our current memorandum and articles of association as set out below, any of our shareholders may transfer all or any of his or her ordinary shares by an instrument of transfer in the usual or common form or any other form approved by our board of directors.
Our board of directors may, in its absolute discretion, decline to register any transfer of any ordinary share which is not fully paid up or on which we have a lien. Our board of directors may also decline to register any transfer of any ordinary share unless:
|
· |
the instrument of transfer is lodged with us, accompanied by the certificate for the ordinary shares to which it relates and such other; |
|
· |
evidence as our board of directors may reasonably require to show the right of the transferor to make the transfer; |
|
· |
the instrument of transfer is in respect of only one class of ordinary shares; |
|
· |
the instrument of transfer is properly stamped, if required; |
|
· |
in the case of a transfer to joint holders, the number of joint holders to whom the ordinary share is to be transferred does not exceed four; and |
|
· |
a fee of such maximum sum as the |
If our directors refuse to register a transfer they shall, within three months after the date on which the instrument of transfer was lodged, send to each of the transferor and the transferee notice of such refusal.
The registration of transfers may, after compliance with any notice required of NYSE, be suspended and the register closed at such times and for such periods as our board of directors may from time to time determine, provided, however, that the registration of transfers shall not be suspended nor the register closed for more than 30 days in any year as our board may determine.
Liquidation. On the winding up of our company, if the assets available for distribution amongst our shareholders shall be more than sufficient to repay the whole of the share capital at the commencement of the winding up, the surplus shall be distributed amongst our shareholders in proportion to the par value of the shares held by them at the commencement of the winding up, subject to a deduction from those shares in respect of which there are monies due, of all monies payable to our company for unpaid calls or otherwise. If our assets available for distribution are insufficient to repay all of the paid-up capital, the assets will be distributed so that the losses are borne by our shareholders in proportion to the par value of the shares held by them.
Calls on Shares and Forfeiture of Shares. Our board of directors may from time to time make calls upon shareholders for any amounts unpaid on their shares in a notice served to such shareholders at least 14 days prior to the specified time and place of payment. The shares that have been called upon and remain unpaid are subject to forfeiture.
Redemption, Repurchase and Surrender of Shares. We may issue shares on terms that such shares are subject to redemption, at our option or at the option of the holders of these shares, on such terms and in such manner as may be determined by our board of directors. Our company may also repurchase any of our shares on such terms and in such manner as have been approved by our board of directors or by an ordinary resolution of our shareholders. Under the Companies Act, the redemption or repurchase of any share may be paid out of our Company's profits or out of the proceeds of a new issue of shares made for the purpose of such redemption or repurchase, or out of capital (including share premium account and capital redemption reserve) if our company can, immediately following such payment, pay its debts as they fall due in the ordinary course of business. In addition, under the Companies Act no such share may be redeemed or repurchased (a) unless it is fully paid up, (b) if such redemption or repurchase would result in there being no shares issued and outstanding or (c) if the company has commenced liquidation. In addition, our company may accept the surrender of any fully paid share for no consideration.
Variations of Rights of Shares. If at any time, our share capital is divided into different classes of shares, the rights attached to any class may be materially adversely varied with the consent in writing of the holders of at least two-thirds (2/3) of the issued shares of that class or with the sanction of a special resolution passed at a separate meeting of the holders of the shares of that class. The rights conferred upon the holders of the shares of any class issued shall not, be deemed to be materially adversely varied by the creation, allotment or issue of further shares ranking pari passu with or subsequent to them or the redemption or purchase of any shares of any class by the Company. The rights of the holders of shares shall not be deemed to be materially adversely varied by the creation or issue of shares with preferred or other rights including, without limitation, the creation of shares with enhanced or weighted voting rights.
Issuance of Additional Shares. Our current memorandum and articles of association authorize our board of directors to issue additional ordinary shares from time to time as our board of directors shall determine, to the extent out of available authorized but unissued ordinary shares.
Our current memorandum and articles of association also authorize our board of directors to establish from time to time one or more series of preferred shares and to determine, with respect to any series of preferred shares, the terms and rights of that series, including:
|
· |
the designation of the series; |
|
· |
the number of shares of the series; |
|
· |
the dividend rights, dividend rates, conversion rights, voting rights; and |
|
· |
the rights and terms of redemption and liquidation preferences. |
Our board of directors may issue preferred shares without action by our shareholders to the extent out of authorized but unissued preferred shares. Issuance of these shares may dilute the voting power of holders of ordinary shares.
Inspection of Books and Records. Holders of our ordinary shares have no general right under
Anti-Takeover Provisions. Some provisions of our current memorandum and articles of association may discourage, delay or prevent a change of control of our company or management that shareholders may consider favorable, including provisions that:
|
· |
authorize our board of directors to issue preferred shares in one or more series and to designate the price, rights, preferences, privileges and restrictions of such preferred shares without any further vote or action by our shareholders; and |
|
· |
limit the ability of shareholders to requisition and convene general meetings of shareholders. |
However, under
|
· |
does not have to file an annual retuof its shareholders with the Registrar of Companies; |
|
· |
is not required to open its register of members for inspection; |
|
· |
does not have to hold an annual general meeting; |
|
· |
may obtain an undertaking against the imposition of any future taxation (such undertakings are usually given for 30 years in the first instance); |
|
· |
may register by way of continuation in another jurisdiction and be deregistered in the |
|
· |
may register as a limited duration company; and |
|
· |
may register as a segregated portfolio company. |
"Limited liability" means that the liability of each shareholder is limited to the amount unpaid by the shareholder on the shares of the company (except in exceptional circumstances, such as involving fraud, the establishment of an agency relationship or an illegal or improper purpose or other circumstances in which a court may be prepared to pierce or lift the corporate veil).
Differences in Corporate Law
The Companies Act is derived, to a large extent, from the older Companies Acts of
Mergers and Similar Arrangements. The Companies Act permits mergers and consolidations between
A merger between a Cayman parent company and its Cayman subsidiary or subsidiaries does not require authorization by a resolution of shareholders of that Cayman subsidiary if a copy of the plan of merger is given to every member of that Cayman subsidiary to be merged unless that member agrees otherwise. For this purpose a company is a "parent" of a subsidiary if it holds issued shares that together represent at least ninety percent (90%) of the votes at a general meeting of the subsidiary.
The consent of each holder of a fixed or floating security interest over a constituent company is required unless this requirement is waived by a court in the
Save in certain limited circumstances, a shareholder of a Cayman constituent company who dissents from the merger or consolidation is entitled to payment of the fair value of his shares (which, if not agreed between the parties, will be determined by the
Separate from the statutory provisions relating to mergers and consolidations, the Companies Act also contains statutory provisions that facilitate the reconstruction and amalgamation of companies by way of schemes of arrangement between the company and its creditors (or any class of them) or its members (or any class of them), provided that (i) any such arrangement with creditors is approved by a majority in number of the creditors (or class of creditors) with whom the arrangement is to be made, who must in addition represent 75% in value of such creditors (or class of creditors), and (ii) any such arrangement with members is approved by 75% in value of the members (or class of members) with whom the arrangement is to be made, that are present and voting either in person or by proxy at a meeting, or meetings, convened for that purpose. The convening of the meetings and subsequently the arrangement must be sanctioned by the
|
· |
the statutory provisions as to the required majority vote have been met; |
|
· |
the shareholders have been fairly represented at the meeting in question and the statutory majority are acting bona fide without coercion of the minority to promote interests adverse to those of the class; |
|
· |
the arrangement is such that may be reasonably approved by an intelligent and honest man of that class acting in respect of his interest; and |
|
· |
the arrangement is not one that would more properly be sanctioned under some other provision of the Companies Act. |
The Companies Act also contains a statutory power of compulsory acquisition which may facilitate the "squeeze out" of dissentient minority shareholders upon a tender offer. When a tender offer is made and accepted by holders of 90.0% of the shares affected within four months, the offeror may, within a two-month period commencing on the expiration of such four-month period, require the holders of the remaining shares to transfer such shares to the offeror on the terms of the offer. An objection can be made to the
If an arrangement and reconstruction by way of scheme of arrangement is thus approved and sanctioned, or if a tender offer is made and accepted in accordance with the foregoing statutory procedures, a dissenting shareholder would have no rights comparable to appraisal rights, which would otherwise ordinarily be available to dissenting shareholders of
Shareholders' Suits. In principle, we will normally be the proper plaintiff to sue for a wrong done to us as a company, and as a general rule a derivative action may not be brought by a minority shareholder. However, based on English authorities, which would in all likelihood be of persuasive authority in the
|
· |
a company acts or proposes to act illegally or ultra vires (and is therefore incapable of ratification by the shareholder); |
|
· |
the act complained of, although not ultra vires, could only be effected duly if authorized by more than a simple majority vote that has not been obtained; and |
|
· |
those who control the company are perpetrating a "fraud on the minority." |
Indemnification of Directors and Executive Officers and Limitation of Liability.
In addition, we have entered into indemnification agreements with our directors and executive officers that provide such persons with additional indemnification beyond that provided in our current memorandum and articles of association.
Insofar as indemnification for liabilities arising under the Securities Act may be permitted to our directors, officers or persons controlling us under the foregoing provisions, we have been informed that in the opinion of the
Directors' Fiduciary Duties. Under
As a matter of
Shareholder Action by Written Consent. Under the Delaware General Corporation Law, a corporation may eliminate the right of shareholders to act by written consent by amendment to its certificate of incorporation.
Shareholder Proposals. Under the Delaware General Corporation Law, a shareholder has the right to put any proposal before the annual meeting of shareholders; provided it complies with the notice provisions in the governing documents. A special meeting may be called by the board of directors or any other person authorized to do so in the governing documents, but shareholders may be precluded from calling special meetings.
The Companies Act provides shareholders with only limited rights to requisition a general meeting, and does not provide shareholders with any right to put any proposal before a general meeting. However, these rights may be provided in a company's articles
of association. Our current memorandum and articles of association allow any one or more of our shareholders holding shares which carry in aggregate not less than one-third of the total number of votes attaching to all issued and the outstanding shares of our company entitled to vote at general meetings to requisition an extraordinary general meeting of our shareholders, in which case our board is obliged to convene an extraordinary general meeting and to put the resolutions so requisitioned to a vote at such meeting. Other than this right to requisition a shareholders' meeting, our current memorandum and articles of association do not provide our shareholders with any other right to put proposals before annual general meetings or extraordinary general meetings. As a
Cumulative Voting. Under the Delaware General Corporation Law, cumulative voting for elections of directors is not permitted unless the corporation's certificate of incorporation specifically provides for it. Cumulative voting potentially facilitates the representation of minority shareholders on a board of directors since it permits the minority shareholder to cast all the votes to which the shareholder is entitled on a single director, which increases the shareholder's voting power with respect to electing such director. There are no prohibitions in relation to cumulative voting under the laws of the
Removal of Directors. Under the Delaware General Corporation Law, a director of a corporation with a classified board may be removed only for cause with the approval of a majority of the issued and outstanding shares entitled to vote, unless the certificate of incorporation provides otherwise. Under our current memorandum and articles of association, directors may be removed with or without cause, by an ordinary resolution of our shareholders. A director will also cease to be a director if he (i) becomes bankrupt or makes any arrangement or composition with his creditors; (ii) dies or is found to be or becomes of unsound mind; (iii) resigns his office by notice in writing; (iv) without special leave of absence from our board, is absent from meetings of our board for three consecutive meetings and our board resolves that his office be vacated; or (v) is removed from office pursuant to any other provision of our articles of association.
Transactions with Interested Shareholders. The Delaware General Corporation Law contains a business combination statute applicable to
Restructuring. A company may present a petition to the
(a) is or is likely to become unable to pay its debts; and
(b) intends to present a compromise or arrangement to its creditors (or classes thereof) either pursuant to the Companies Act, the law of a foreign country or by way of a consensual restructuring.
The Grand Court may, among other things, make an order appointing a restructuring officer upon hearing of such petition, and any restructuring officer so appointed shall have such powers and carry out such functions as the court may order. At any time (i) after the presentation of a petition for the appointment of a restructuring officer but before an order for the appointment of a restructuring officer has been made, and (ii) when an order for the appointment of a restructuring officer is made, until such order has been discharged, no suit, action or other proceedings (other than criminal proceedings) shall be proceeded with or commenced against the company, no resolution to wind up the company shall be passed, and no winding up petition may be presented against the company, except with the leave of the court and subject to such terms as the court may impose. However, notwithstanding the presentation of a petition for the appointment of a restructuring officer or the appointment of a restructuring officer, a creditor who has security over the whole or part of the assets of the company is entitled to enforce the security without the leave of the court and without reference to the restructuring officer appointed.
Dissolution; Winding up. Under the Delaware General Corporation Law, unless the board of directors approves the proposal to dissolve, dissolution must be approved by shareholders holding 100% of the total voting power of the corporation. Only if the dissolution is initiated by the board of directors may it be approved by a simple majority of the corporation's outstanding shares.
Under
Variation of Rights of Shares. Under the Delaware General Corporation Law, a corporation may vary the rights of a class of shares with the approval of a majority of the outstanding shares of such class, unless the certificate of incorporation provides otherwise. Under our current memorandum and articles of association, if our share capital is divided into more than one class of shares, the rights attached to any such class may, subject to any rights or restrictions for the time being attached to any class, only be materially adversely varied with the consent in writing of the holders of at least two-thirds (2/3) of the issued shares of that class or with the sanction of a special resolution passed at a separate meeting of the holders of the shares of that class. The rights conferred upon the holders of the shares of any class issued with preferred or other rights shall not, subject to any rights or restrictions for the time being attached to the shares of that class, be deemed to be materially adversely varied by the creation, allotment or issue of further shares ranking pad passu with or subsequent to them or the redemption or purchase of any shares of any class by our company. The rights of the holders of shares shall not be deemed to be materially adversely varied by the creation or issue of shares with preferred or other rights including, without limitation, the creation of shares with enhanced or weighted voting rights.
Amendment of Governing Documents. Under the Delaware General Corporation Law, a corporation's governing documents may be amended with the approval of a majority of the outstanding shares entitled to vote, unless the certificate of incorporation provides otherwise. Under the Companies Act and our current memorandum and articles of association, our memorandum and articles of association may only be amended by a special resolution of our shareholders.
Rights of Non-resident or Foreign Shareholders. There are no limitations imposed by our current memorandum and articles of association on the rights of non-resident or foreign shareholders to hold or exercise voting rights on our shares. In addition, there are no provisions in our current memorandum and articles of association governing the ownership threshold above which shareholder ownership must be disclosed.
|
C. |
Material Contracts |
Other than in the ordinary course of business and other than those described in "Item 4. Information on the Company" or "Item 7. Major Shareholders and Related Party Transactions-B. Related Party Transactions" or elsewhere in this annual report, we have not entered into any material contract during the two years immediately preceding the date of this annual report.
|
D. |
Exchange Controls |
See "Item 4. Information on the
|
E. |
Taxation |
The following summary of the material
Cayman Islands Taxation
The
Payments of dividends and capital in respect of our ordinary shares and ADSs will not be subject to taxation in the
Mainland China Taxation
Under the PRC Enterprise Income Tax Law and its implementation rules, an enterprise established outside of mainland China with a "de facto management body" within mainland China is considered a resident enterprise and will be subject to the enterprise income tax at the rate of 25% on its global income. The implementation rules define the term "de facto management body" as the body that exercises full and substantial control over and overall management of the business, production, personnel, accounts and properties of an enterprise. In
We believe that
If the PRC tax authorities determine that
Provided that our
United States Federal Income Tax Considerations
The following discussion is a summary of
|
· |
banks and other financial institutions; |
|
· |
insurance companies; |
|
· |
pension plans; |
|
· |
cooperatives; |
|
· |
regulated investment companies; |
|
· |
real estate investment trusts; |
|
· |
broker-dealers; |
|
· |
traders that elect to use a mark-to-market method of accounting; |
|
· |
certain former |
|
· |
tax-exempt entities (including private foundations); |
|
· |
holders who acquire their ADSs or ordinary shares pursuant to any employee share option or otherwise as compensation; |
|
· |
investors that hold their ADSs or ordinary shares as part of a straddle, hedge, conversion, constructive sale or other integrated transaction for |
|
· |
investors that have a functional currency other than the |
|
· |
persons holding their ADSs or ordinary shares in connection with a trade or business conducted outside |
|
· |
persons that directly, indirectly or constructively own 10% or more of our stock (by vote or value); or |
|
· |
partnerships or other entities taxable as partnerships for |
Each
General
For purposes of this discussion, a "
|
· |
an individual who is a citizen or resident of |
|
· |
a corporation (or other entity treated as a corporation for |
|
· |
an estate the income of which is includible in gross income for |
|
· |
a trust (A) the administration of which is subject to the primary supervision of a |
If a partnership (or other entity treated as a partnership for
For
Passive Foreign Investment Company Considerations
A non-
Although the law in this regard is not entirely clear, we treat the VIEs and their subsidiaries as being owned by us for
Based upon the nature and composition of our assets (in particular, the retention of substantial amounts of cash and investments), and the market price of our ADSs, we believe that we were a PFIC for
If we are a PFIC for any year during which a
Dividends
Subject to the discussion below under "Passive Foreign Investment Company Rules," the gross amount of any distributions paid on the ADSs or ordinary shares (including the amount of any mainland China tax withheld) out of our current or accumulated earnings and profits, as determined under
Individuals and other non-corporate
In the event that we are deemed to be a mainland China resident enterprise under the PRC Enterprise Income Tax Law (see "Item 10. Additional Information-E. Taxation-Mainland China Taxation"), we may be eligible for the benefits of the Treaty. If we are eligible for such benefits, dividends we pay on our ordinary shares, regardless of whether such shares are represented by the ADSs, and regardless of whether the ADSs are readily tradable on an established securities market in
For
As mentioned above, we believe that we were a PFIC for the taxable year ended
Sale or Other Disposition
Subject to the discussion below under "Passive Foreign Investment Company Rules," a
As described in "Item 10. Additional Information-E. Taxation-Mainland China Taxation," if we are deemed to be a mainland China resident enterprise under the PRC Enterprise Income Tax Law, gains from the disposition of the ADSs or ordinary shares may be subject to mainland China income tax and will generally be
As mentioned above, we believe that we were a PFIC for the taxable year ended
Passive Foreign Investment Company Rules
If we are a PFIC for any taxable year during which a
|
· |
the excess distribution or gain will be allocated ratably over the |
|
· |
the amount allocated to the current taxable year and any taxable years in the |
|
· |
the amount allocated to each prior taxable year, other than a pre-PFIC year, will be subject to tax at the highest tax rate in effect for individuals or corporations, as appropriate, for that year, increased by an additional tax equal to the interest on the resulting tax deemed deferred with respect to each such taxable year. |
If we are a PFIC for any taxable year during which a
As an alternative to the foregoing rules, a
The mark-to-market election is available only for "marketable stock," which is stock that is traded in other than de minimis quantities on at least 15 days during each calendar quarter ("regularly traded") on a qualified exchange or other market, as defined in applicable Treasury Regulations. For this purpose, our ADSs, but not our ordinary shares, are listed on the
Because a mark-to-market election cannot technically be made for any lower-tier PFICs that we may own, a
We do not intend to provide information necessary for
If a
|
F. |
Dividends and Paying Agents |
Not applicable.
|
G. |
Statement by Experts |
Not applicable.
|
H. |
Documents on Display |
We are subject to periodic reporting and other informational requirements of the Exchange Act as applicable to foreign private issuers, and are required to file reports and other information with the
We will furnish
|
I. |
Subsidiary Information |
Not applicable.
|
J. |
Annual Report to Security Holders |
Not applicable.
Item 11.Quantitative and Qualitative Disclosures about Market Risk
Foreign exchange risk
Substantially all of our net revenues and expenses are denominated in Renminbi. We do not believe that we currently have any significant direct foreign exchange risk and have not used any derivative financial instruments to hedge exposure to such risk. Although our exposure to foreign exchange risks should be limited in general, the value of your investment in our ADSs will be affected by the exchange rate between
The conversion of Renminbi into other currencies, including
To the extent that we need to convert the
As of
Concentration of credit risk
Details of the customers accounting for 10% or more of net operating revenue are as follows, including the amount of net operating revenue and as percentages of total net operating revenue for the periods presented:
|
​ |
​ |
​ |
​ |
​ |
​ |
​ |
​ |
​ |
​ |
​ |
​ |
​ |
|
​ |
​ |
For the Year Ended |
||||||||||
|
​ |
​ |
2022 |
​ |
2023 |
​ |
2024 |
||||||
|
​ |
​ |
RMB in |
​ |
​ |
​ |
RMB in |
​ |
​ |
​ |
RMB in |
​ |
​ |
|
​ |
​ |
thousands |
​ |
% |
​ |
thousands |
​ |
% |
​ |
thousands |
​ |
% |
|
Customer A |
320,660 |
11.4 |
* |
* |
* |
* |
||||||
|
Customer B |
357,202 |
12.8 |
* |
* |
* |
* |
||||||
​
Details of the customers which accounted for 10% or more of accounts receivable and contract assets are as follows, including the amount of accounts receivable and contract assets and as percentages of total accounts receivable and contract assets for the periods presented:
|
​ |
​ |
​ |
​ |
​ |
​ |
​ |
​ |
​ |
|
​ |
​ |
As of |
||||||
|
​ |
​ |
2023 |
​ |
2024 |
||||
|
​ |
​ |
RMB in |
​ |
​ |
​ |
RMB in |
​ |
​ |
|
​ |
​ |
thousands |
​ |
% |
​ |
thousands |
​ |
% |
|
Customer C |
168,394 |
12.0 |
* |
* |
||||
|
Customer D |
* |
* |
234,744 |
15.8 |
||||
​
We perform ongoing credit evaluations of our customers and generally do not require collateral on accounts receivable.
Item 12.Description of Securities Other than
|
A. |
|
Not applicable.
|
B. |
Warrants and Rights |
Not applicable.
|
C. |
Other Securities |
Not applicable.
|
D. |
American Depositary Shares |
Fees and Charges Our ADS holders
As an ADS holder, you will be required to pay the following fees under the terms of the deposit agreement:
|
Service |
Fees |
|
|
Issuance of ADSs (e.g., an issuance of ADS upon a deposit of Class A ordinary shares, upon a change in the ADS(s)-to-Class A ordinary share ratio, or for any other reason), excluding ADS issuances as a result of distributions of Class A ordinary shares |
​ |
Up to |
|
​ |
​ |
​ |
|
Cancellation of ADSs (e.g., a cancellation of ADSs for delivery of deposited property, upon a change in the ADS(s)-to-Class A ordinary share ratio, or for any other reason) |
​ |
Up to |
|
​ |
​ |
​ |
|
Distribution of cash dividends or other cash distributions (e.g., upon a sale of rights and other entitlements) |
​ |
Up to |
|
​ |
​ |
​ |
|
Distribution of ADSs pursuant to (i) stock dividends or other free stock distributions, or (ii) exercise of rights to purchase additional ADSs |
​ |
Up to |
|
​ |
​ |
​ |
|
Distribution of securities other than ADSs or rights to purchase additional ADSs (e.g., upon a spin-off) |
​ |
Up to |
|
​ |
​ |
​ |
|
|
​ |
Up to |
|
​ |
​ |
​ |
|
Registration of ADS transfers (e.g., upon a registration of the transfer of registered ownership of ADSs, upon a transfer of ADSs into DTC and vice versa, or for any other reason) |
​ |
Up to |
|
​ |
​ |
​ |
|
Conversion of ADSs of one series for ADSs of another series (e.g., upon conversion of Partial Entitlement ADSs for Full Entitlement ADSs, or upon conversion of Restricted ADSs (each as defined in the Deposit Agreement) into freely transferable ADSs, and vice versa). |
​ |
Up to |
​
As an ADS holder, you are also responsible to pay certain charges, such as:
| â—Ź | taxes (including applicable interest and penalties) and other governmental charges; |
| â—Ź | the registration fees as may from time to time be in effect for the registration of Class A ordinary shares on the share register and applicable to transfers of Class A ordinary shares to or from the name of the custodian, the depositary or any nominees upon the making of deposits and withdrawals, respectively; |
| â—Ź | certain cable, telex and facsimile transmission and delivery expenses; |
| â—Ź | the fees, expenses, spreads, taxes and other charges of the depositary and/or service providers (which may be a division, branch or affiliate of the depositary) in the conversion of foreign currency; |
| â—Ź | the reasonable and customary out-of-pocket expenses incurred by the depositary in connection with compliance with exchange control regulations and other regulatory requirements applicable to Class A ordinary shares, ADSs and ADRs; and |
| â—Ź | the fees, charges, costs and expenses incurred by the depositary, the custodian, or any nominee in connection with the ADR program. |
ADS fees and charges for (i) the issuance of ADSs, and (ii) the cancellation of ADSs are charged to the person for whom the ADSs are issued (in the case of ADS issuances) and to the person for whom ADSs are cancelled (in the case of ADS cancellations). In the case of ADSs issued by the depositary into DTC, the ADS issuance and cancellation fees and charges may be deducted from distributions made through DTC, and may be charged to the DTC participant(s) receiving the ADSs being issued or the DTC participant(s) holding the ADSs being cancelled, as the case may be, on behalf of the beneficial owner(s) and will be charged by the DTC participant(s) to the account of the applicable beneficial owner(s) in accordance with the procedures and practices of the DTC participants as in effect at the time. ADS fees and charges in respect of distributions and the ADS service fee are charged to the holders as of the applicable ADS record date. In the case of distributions of cash, the amount of the applicable ADS fees and charges is deducted from the funds being distributed. In the case of (i) distributions other than cash and (ii) the ADS service fee, holders as of the ADS record date will be invoiced for the amount of the ADS fees and charges and such ADS fees and charges may be deducted from distributions made to holders of ADSs. For ADSs held through DTC, the ADS fees and charges for distributions other than cash and the ADS service fee may be deducted from distributions made through DTC, and may be charged to the DTC participants in accordance with the procedures and practices prescribed by DTC and the DTC participants in tucharge the amount of such ADS fees and charges to the beneficial owners for whom they hold ADSs. In the case of (i) registration of ADS transfers, the ADS transfer fee will be payable by the ADS holder whose ADSs are being transferred or by the person to whom the ADSs are transferred, and (ii) conversion of ADSs of one series for ADSs of another series, the ADS conversion fee will be payable by the holder whose ADSs are converted or by the person to whom the converted ADSs are delivered.
In the event of refusal to pay the depositary fees, the depositary may, under the terms of the deposit agreement, refuse the requested service until payment is received or may set off the amount of the depositary fees from any distribution to be made to the ADS holder. Certain depositary fees and charges (such as the ADS services fee) may become payable shortly after the closing of the ADS offering. Note that the fees and charges you may be required to pay may vary over time and may be changed by us and by the depositary. You will receive prior notice of such changes.
Fees and Other Payments Made by the Depositary to Us
The depositary may reimburse us for certain expenses incurred by us in respect of the ADR program, by making available a portion of the ADS fees charged in respect of the ADR program or otherwise, upon such terms and conditions as we and the depositary agree from time to time. Responsibility for payment of such fees, charges and reimbursements may from time to time be changed by agreement between us and the depositary. In the year ended
Taxes
You will be responsible for the taxes and other governmental charges payable on the ADSs and the securities represented by the ADSs. We, the depositary and the custodian may deduct from any distribution the taxes and governmental charges payable by holders and may sell any and all property on deposit to pay the taxes and governmental charges payable by holders. You will be liable for any deficiency if the sale proceeds do not cover the taxes that are due.
The depositary may refuse to issue ADSs, to deliver, transfer, split and combine ADRs or to release securities on deposit until all taxes and charges are paid by the applicable holder. The depositary and the custodian may take reasonable administrative actions to obtain tax refunds and reduced tax withholding for any distributions on your behalf. However, you may be required to provide to the depositary and to the custodian proof of taxpayer status and residence and such other information as the depositary and the custodian may require to fulfill legal obligations. You are required to indemnify us, the depositary and the custodian for any claims with respect to taxes based on any tax benefit obtained for you.
PART II
Item 13.Defaults, Dividend Arrearages and Delinquencies
None.
Item 14.Material Modifications to the Rights of Security Holders and Use of Proceeds
Material Modifications to the Rights of Security Holders
None.
Use of Proceeds
The following "Use of Proceeds" information relates to the registration statement on Form F-1 for our IPO (File Number 333-255298), which was declared effective by the
For the period from
There is no material change in the use of proceeds as described in the registration statement.
Item 15.Controls and Procedures
Evaluation of Disclosure Controls and Procedures
Our management, under the supervision and with the participation of our chief executive officer and head of finance, carried out an evaluation of the effectiveness of our disclosure controls and procedures, which is defined in Rules 13a-15(e) of the Exchange Act, as of
Based upon that evaluation, our management, with the participation of our chief executive officer and head of finance, has concluded that our disclosure controls and procedures were effective as of
Management's Annual Report on Internal Control over Financial Reporting
Our management is responsible for establishing and maintaining adequate internal control over financial reporting, as such term is defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act of 1934. Our internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of consolidated financial statements in accordance with
Our management conducted an assessment of the effectiveness of our internal control over financial reporting as of
Attestation Report of the Registered Public Accounting Firm
This annual report does not include an attestation report of our independent registered public accounting firm regarding internal control over financial reporting. As a company with less than
Changes in Internal Control over Financial Reporting
Other than as described above, there were no changes in our internal controls over financial reporting that occurred during the period covered by this annual report on Form 20-F that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.
Item 16A.Audit Committee Financial Expert
Our board of directors has determined that Mr.
Item 16B.Code of Ethics
Our board of directors adopted a code of business conduct and ethics that applies to our directors, officers and employees in
Item 16C.Principal Accountant Fees and Services
The following table sets forth the aggregate fees by categories specified below in connection with certain professional services rendered by
|
​ |
​ |
​ |
​ |
​ |
​ |
​ |
|
​ |
2023 |
2024 |
||||
|
​ |
​ |
(in thousands) |
||||
|
Audit fees(1) |
US$ |
1,635 |
​ |
US$ |
1,494 |
|
|
All other fees(2) |
​ |
US$ |
11 |
​ |
US$ |
- |
|
(1) |
"Audit fees" means the aggregate fees billed in each of the fiscal years listed for professional services rendered by our principal auditors for the audit of our annual financial statements and assistance with and review of documents filed with the |
|
(2) |
"All other fees" means the aggregate fees billed in each of the fiscal years listed for professional services rendered by our principal auditors associated with certain permitted tax services. |
The policy of our audit committee is to pre-approve all audit and non-audit services provided by
Item 16D.Exemptions from the Listing Standards for Audit Committees
Not applicable.
Item 16E.Purchases of
On
The following table sets forth information about our repurchases made in the year 2024 and the first three months of 2025 under the share repurchase programs described above.
|
​ |
​ |
​ |
​ |
​ |
​ |
​ |
​ |
​ |
|
​ |
​ |
​ |
​ |
(d) Maximum |
||||
|
​ |
​ |
​ |
​ |
​ |
​ |
​ |
​ |
Dollar Value of |
|
​ |
​ |
​ |
​ |
​ |
​ |
(c) Total |
​ |
ADSs that May |
|
​ |
​ |
​ |
​ |
​ |
​ |
Number of ADSs |
​ |
Yet be |
|
​ |
​ |
​ |
​ |
​ |
​ |
Purchased as |
​ |
Purchased |
|
​ |
​ |
​ |
​ |
​ |
​ |
Part of Publicly |
​ |
Under the Share |
|
​ |
​ |
(a) Total |
​ |
(b) Average |
​ |
Announced |
​ |
Repurchase |
|
​ |
​ |
Number of ADSs |
​ |
Price Paid per |
​ |
Share Repurchase |
​ |
Programs (US$ in |
|
Period |
​ |
Purchased |
​ |
ADS (US$) |
​ |
Programs(1) |
​ |
thousands))(2) |
|
|
​ |
408,467 |
1.01 |
39,167,546 |
48,580 |
|||
|
|
​ |
559,628 |
1.10 |
39,727,174 |
47,962 |
|||
|
|
​ |
1,539,000 |
1.21 |
41,266,174 |
46,099 |
|||
|
|
​ |
2,212,000 |
1.23 |
43,478,174 |
43,388 |
|||
|
May 1 - May 31, 2024 |
​ |
2,050,008 |
1.25 |
45,528,182 |
40,826 |
|||
|
June 1 - June 30, 2024 |
​ |
2,278,006 |
1.25 |
47,806,188 |
37,979 |
|||
|
July 1 - July 31, 2024 |
​ |
1,253,000 |
1.15 |
49,059,188 |
36,540 |
|||
|
August 1 - August 31, 2024 |
​ |
222,436 |
1.05 |
49,281,624 |
36,306 |
|||
|
September 1 - September 7, 2024 |
​ |
25,395 |
1.09 |
49,307,019 |
36,278 |
|||
|
September 8 - September 30, 2024 |
​ |
175,846 |
1.10 |
49,482,865 |
49,806 |
|||
|
October 1 - October 31, 2024 |
​ |
931,325 |
1.20 |
50,414,190 |
48,690 |
|||
|
November 1 - November 30, 2024 |
​ |
508,803 |
1.13 |
50,922,993 |
48,114 |
|||
|
December 1 - December 31, 2024 |
​ |
192,686 |
1.15 |
51,115,679 |
47,893 |
|||
|
January 1 - January 31, 2025 |
​ |
551,908 |
1.18 |
51,667,587 |
47,241 |
|||
|
February 1 - February 28, 2025 |
​ |
402,125 |
1.30 |
52,069,712 |
46,720 |
|||
|
March 1 - March 31, 2025 |
​ |
937,559 |
1.41 |
53,007,271 |
45,402 |
|||
|
Total |
​ |
14,248,192 |
1.22 |
53,007,271 |
N/A |
​
|
(1) |
The total number of ADSs purchased as part of the publicly announced plans presented under this column represents the cumulative total number of ADSs repurchased pursuant to the share repurchase programs adopted on September 6, 2023 and September 4, 2024. |
(2)The approximate dollar value of ADSs that may yet be purchased under the plans presented under this column for January 2024 to September 2024 refers to the approximate dollar value of ADSs that may yet be purchased under the share repurchase program announced on September 7, 2023, and the approximate dollar value of ADSs that may yet be purchased under the plans presented under this column for the other months in 2024 and for the first three months in 2025 refers to the approximate dollar value of ADSs that may yet be purchased under the share repurchase programs announced on September 4, 2024.
​
​
Attachments
Disclaimer



Legislative work continues despite the lack of a state budget
Economic optimism low among Midwest bankers, supply managers; North Dakota exports down
Advisor News
- Mitigating recession-based client anxiety
- Terri Kallsen begins board chair role at CFP Board
- Advisors underestimate demand for steady, guaranteed income, survey shows
- D.C. Digest: 'One Big Beautiful Bill' rebranded 'Working Families Tax Cut'
- OBBBA and New Year’s resolutions
More Advisor NewsAnnuity News
- MetLife Declares First Quarter 2026 Common Stock Dividend
- Using annuities as a legacy tool: The ROP feature
- Jackson Financial Inc. and TPG Inc. Announce Long-Term Strategic Partnership
- An Application for the Trademark “EMPOWER PERSONAL WEALTH” Has Been Filed by Great-West Life & Annuity Insurance Company: Great-West Life & Annuity Insurance Company
- Talcott Financial Group Launches Three New Fixed Annuity Products to Meet Growing Retail Demand for Secure Retirement Income
More Annuity NewsHealth/Employee Benefits News
- Wyoming's catastrophic 'BearCare' health insurance plan could become reality
- Duckworth pushes military IVF coverage as critics warn taxpayers could pay
- House to consider extension for expired ACA subsidies
- Health insurance costs spike after key ACA subsidies end
- Veterans defend nonprofit exec accused of theft
More Health/Employee Benefits NewsLife Insurance News